Coya Therapeutics, Inc. COYA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 43.18M | 50.72M | 46.82M | 28.13M | 29.76M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.88M | 2.54M | 3.12M | 3.89M | 3.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.06M | 53.26M | 49.94M | 32.02M | 33.43M |
|
|
|||||
| Total Current Assets | 47.06M | 53.26M | 49.94M | 32.02M | 33.43M |
| Net Property, Plant & Equipment | 5.60K | 8.40K | 11.20K | 18.10K | 24.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 244.70K | -- | -- | -- | -- |
| Total Assets | 47.31M | 53.27M | 49.95M | 32.04M | 33.45M |
|
|
|||||
| Total Accounts Payable | 1.09M | 948.20K | 1.06M | 1.11M | 931.30K |
| Total Accrued Expenses | 1.19M | 1.36M | 3.61M | 1.64M | 2.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.23M | 1.24M | 1.20M | 916.70K | 731.10K |
| Total Other Current Liabilities | 1.23M | 1.24M | 1.20M | 916.70K | 731.10K |
| Total Current Liabilities | 3.51M | 3.55M | 5.87M | 3.67M | 4.50M |
|
|
|||||
| Total Current Liabilities | 3.51M | 3.55M | 5.87M | 3.67M | 4.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 519.60K | 754.20K | 1.05M | 1.09M | 641.20K |
| Total Liabilities | 4.03M | 4.30M | 6.92M | 4.76M | 5.14M |
|
|
|||||
| Common Stock & APIC | 119.08M | 118.14M | 104.99M | 83.54M | 82.45M |
| Retained Earnings | -75.81M | -69.17M | -61.96M | -56.25M | -54.14M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 43.28M | 48.97M | 43.03M | 27.28M | 28.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.28M | 48.97M | 43.03M | 27.28M | 28.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.28M | 48.97M | 43.03M | 27.28M | 28.31M |
|
|
|||||